Evidence map›Paper›PMID 36497355›Full record

ArticleCancers2022

Attention Cost-Sensitive Deep Learning-Based Approach for Skin Cancer Detection and Classification.

Vinayakumar Ravi

Open access · goldAbstract read
In one paragraph

Article in Cancers, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
4.2field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 41 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Vinayakumar RaviCenter for Artificial Intelligence, Prince Mohammad Bin Fahd University, Khobar 34754, Saudi Arabia.ORCID 0000-0001-6873-6469
Prince Mohammad bin Fahd University · SA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Deep learning-based models have been employed for the detection and classification of skin diseases through medical imaging. However, deep learning-based models are not effective for rare skin disease detection and classification. This is mainly due to the reason that rare skin disease has very a smaller number of data samples. Thus, the dataset will be highly imbalanced, and due to the bias in learning, most of the models give better performances. The deep learning models are not effective in detecting the affected tiny portions of skin disease in the overall regions of the image. This paper presents an attention-cost-sensitive deep learning-based feature fusion ensemble meta-classifier approach for skin cancer detection and classification. Cost weights are included in the deep learning models to handle the data imbalance during training. To effectively learn the optimal features from the affected tiny portions of skin image samples, attention is integrated into the deep learning models. The features from the finetuned models are extracted and the dimensionality of the features was further reduced by using a kernel-based principal component (KPCA) analysis. The reduced features of the deep learning-based finetuned models are fused and passed into ensemble meta-classifiers for skin disease detection and classification. The ensemble meta-classifier is a two-stage model. The first stage performs the prediction of skin disease and the second stage performs the classification by considering the prediction of the first stage as features. Detailed analysis of the proposed approach is demonstrated for both skin disease detection and skin disease classification. The proposed approach demonstrated an accuracy of 99% on skin disease detection and 99% on skin disease classification. In all the experimental settings, the proposed approach outperformed the existing methods and demonstrated a performance improvement of 4% accuracy for skin disease detection and 9% accuracy for skin disease classification. The proposed approach can be used as a computer-aided diagnosis (CAD) tool for the early diagnosis of skin cancer detection and classification in healthcare and medical environments. The tool can accurately detect skin diseases and classify the skin disease into their skin disease family.

Indexed as

attentioncost-sensitivedeep learningmeta-classifierskin diseasetransfer learning

Identifiers

PMID36497355
PMCPMC9735681
OpenAlexW4310989423

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.